Malaria incidence in children in South-West Burkina Faso: Comparison of active and passive case detection methods

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Tiono, Alfred B ^a   Kangoye, David T ^a   Rehman, Andrea M ^b   Kargougou, Désiré G ^a   Kaboré, Youssouf ^a   Diarra, Amidou ^a   Ouedraogo, Esperance ^a   Nébié, Issa ^a   Ouédraogo, Alphonse ^a   Okech, Brenda ^c   Milligan, Paul ^b   Sirima, Sodiomon B ^a  

^a Burkina Faso   (Burkina Faso)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Statens Serum Institute   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE CASE DETECTION; ARTICLE; BLOOD SMEAR; BURKINA FASO; CASE FINDING; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SURVEILLANCE; FEMALE; FEVER; FOLLOW UP; HUMAN; INCIDENCE; MALARIA; MALARIA RAPID TEST; MALE; PARASITEMIA; PASSIVE CASE DETECTION; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; SENSITIVITY AND SPECIFICITY; TYMPANIC TEMPERATURE; EPIDEMIOLOGICAL MONITORING; ERYTHROCYTE; GROWTH, DEVELOPMENT AND AGING; INFANT; MALARIA, FALCIPARUM; NEWBORN; PARASITOLOGY; PATHOPHYSIOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RISK; SEASON;

BURKINA FASO; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; ERYTHROCYTES; FEMALE; FEVER; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; RISK; SEASONS;

EID: 84899789352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086936     Document Type: Article

References (19)

1. De Allegri M, Louis VR, Tiendrebeogo J, Souares A, Ye M, et al. (2013) Moving towards universal coverage with malaria control interventions: achievements and challenges in rural Burkina Faso. Int J Health Plann Manage 28: 102-121.
2. Badolo A, Traore A, Jones CM, Sanou A, Flood L, et al. (2012) Three years of insecticide resistance monitoring in Anopheles gambiae in Burkina Faso: resistance on the rise? Malar J 11: 232.
3. Dabire RK, Namountougou M, Sawadogo SP, Yaro LB, Toe HK, et al. (2012) Population dynamics of Anopheles gambiae s.l. in Bobo-Dioulasso city: bionomics, infection rate and susceptibility to insecticides. Parasit Vectors 5: 127.
4. Kwiatkowska RM, Platt N, Poupardin R, Irving H, Dabire RK, et al. (2013) Dissecting the mechanisms responsible for the multiple insecticide resistance phenotype in Anopheles gambiae s.s., M form, from Vallee du Kou, Burkina Faso. Gene 519: 98-106.
5. Diarra A, Nebie I, Tiono A, Sanon S, Soulama I, et al. (2012) Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso. Parasit Vectors 5: 103.
6. WHO (2012) World Malaria Report 2012. Available: http://www.who.int/iris/ bitstream/10665/78945/1/9789241564533-eng.pdf. Accessed 2013 July 1.
7. Konate AT, Yaro JB, Ouedraogo AZ, Diarra A, Gansane A, et al. (2011) Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. PLoS One 6: e23391.
8. Ouedraogo A, Tiono AB, Diarra A, Sanon S, Yaro JB, et al. (2013) Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso. PLoS One 8: e50036.
9. Moorthy VS, Reed Z, Smith PG, Committee WHOMVA (2009) MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials-scientific, regulatory and public health perspectives. Vaccine 27: 624-628.
10. Snow RW, Menon A, Greenwood BM (1989) Measuring morbidity from malaria. Ann Trop Med Parasitol 83: 321-323. (Pubitemid 19183528)
11. Olotu A, Fegan G, Williams TN, Sasi P, Ogada E, et al. (2010) Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya. PLoS One 5: e15569.
12. (DGISS): MdlS (2009) Annuaire Statistique 2008 du Burkina; Juin 2009.
13. WHO (2012) WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Available: http://wwwwhoint/malaria/ mpac/feb2012/smc-policy-recommendationpdf. Accessed 2013 July 1.
14. Belard S, Issifou S, Hounkpatin AB, Schaumburg F, Ngoa UA, et al. (2011) A randomized controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children. PLoS One 6: e22525.
15. Esen M, Kremsner PG, Schleucher R, Gassler M, Imoukhuede EB, et al. (2009) Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate. Vaccine 27: 6862-6868.
16. Mordmuller B, Szywon K, Greutelaers B, Esen M, Mewono L, et al. (2010) Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon. Vaccine 28: 6698-6703.
17. Olotu A, Fegan G, Wambua J, Nyangweso G, Ogada E, et al. (2012) Estimating individual exposure to malaria using local prevalence of malaria infection in the field. PLoS One 7: e32929.
18. Dicko A, Mantel C, Kouriba B, Sagara I, Thera MA, et al. (2005) Season, fever prevalence and pyrogenic threshold for malaria disease definition in an endemic area of Mali. Trop Med Int Health 10: 550-556. (Pubitemid 40806661)
19. Rogers WO, Atuguba F, Oduro AR, Hodgson A, Koram KA (2006) Clinical case definitions and malaria vaccine efficacy. J Infect Dis 193: 467-473. (Pubitemid 43122349)